530207 — Brawn Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹76.21m
- IN₹60.62m
- IN₹169.78m
Annual cashflow statement for Brawn Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -4.12 | -15.4 | -18 | 0.011 |
| Depreciation | ||||
| Non-Cash Items | -0.348 | 0.066 | 0.41 | 0.409 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | 6.55 | 14.6 | 16.9 | -0.521 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Taxes Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 3.18 | -0.256 | 0.474 | 1.12 |
| Capital Expenditures | -0.956 | -0.121 | -2.42 | -0.262 |
| Purchase of Fixed Assets | ||||
| Cash from Investing Activities | -0.956 | -0.121 | -2.42 | -0.262 |
| Financing Cash Flow Items | -0.082 | -0.038 | -0.037 | -0.045 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -0.082 | -0.038 | -0.037 | -0.045 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 2.14 | -0.415 | -1.98 | 0.812 |